ARTICLE | Clinical News
Amgen regulatory update
October 23, 1995 7:00 AM UTC
The Thousand Oaks, Calif., company announced it will submit a PLA for Infergen consensus interferon to treat chronic hepatitis C (see BioCentury, July 24). ...
The Thousand Oaks, Calif., company announced it will submit a PLA for Infergen consensus interferon to treat chronic hepatitis C (see BioCentury, July 24). ...